582286141	582286141	CD	B-NP	O
|	|	NN	I-NP	O
MBMH	MBMH	NN	I-NP	O
|	|	NN	I-NP	O
08412267	08412267	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
151944	151944	CD	B-NP	O
|	|	CC	I-NP	O
2/10/2000	2/10/2000	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
RULE	RULE	NNP	I-NP	I-protein
OUT	OUT	NNP	I-NP	I-protein
MYOCARDIAL	MYOCARDIAL	NNP	I-NP	I-protein
INFARCTION	INFARCTION	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/18/2000	10/18/2000	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/20/2000	10/20/2000	CD	B-NP	O
PRINCIPAL	PRINCIPAL	JJ	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
CORONARY	CORONARY	NN	B-NP	O
ARTERY	ARTERY	NN	I-NP	O
DISEASE	DISEASE	NN	I-NP	O
.	.	.	O	O

OTHER	OTHER	NNP	B-NP	O
PROBLEMS	PROBLEMS	NNP	I-NP	O
:	:	:	O	O
Diabetes	Diabete	NNS	B-NP	O
,	,	,	O	O
asthma	asthma	NN	B-NP	O
,	,	,	O	O
smoking	smoking	NN	B-NP	O
,	,	,	O	O
GI	GI	NN	B-NP	O
bleeding	bleeding	NN	I-NP	O
of	of	IN	B-PP	O
unknown	unknown	JJ	B-NP	O
etiology	etiology	NN	I-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
hypercholesterolemia	hypercholesterolemia	NN	B-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
71-year-old	71-year-old	JJ	I-NP	O
man	man	NN	I-NP	O
with	with	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
with	with	IN	B-PP	O
risk	risk	NN	B-NP	O
factors	factor	NNS	I-NP	O
of	of	IN	B-PP	O
diabetes	diabetes	NN	B-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
cigarette	cigarette	NN	B-NP	O
smoking	smoking	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
report	report	NN	I-NP	O
of	of	IN	B-PP	O
hypercholesterolemia	hypercholesterolemia	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
reported	report	VBN	I-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
angina	angina	NN	B-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
past	past	JJ	I-NP	O
several	several	JJ	I-NP	O
years	year	NNS	I-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
well	well	RB	I-VP	O
controlled	control	VBN	I-VP	O
by	by	IN	B-PP	O
nitroglycerin	nitroglycerin	NN	B-NP	B-protein
.	.	.	O	O

In	In	IN	B-PP	O
October	October	NNP	B-NP	O
of	of	IN	B-PP	O
1997	1997	CD	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
exercise	exercise	VB	I-VP	O
3	3	CD	B-NP	O
minutes	minute	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Bruce	Bruce	NNP	I-NP	O
protocol	protocol	NN	I-NP	O
with	with	IN	B-PP	O
maximum	maximum	JJ	B-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
79	79	CD	B-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
of	of	IN	B-PP	O
over	over	IN	B-NP	O
80	80	CD	I-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
ischemia	ischemia	NN	B-NP	O
on	on	IN	B-PP	O
EKG	EKG	NN	B-NP	B-protein
.	.	.	O	O

An	An	DT	B-NP	O
echo	echo	NN	I-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	B-ADVP	O
normal	normal	JJ	B-ADJP	O
.	.	.	O	O

About	About	IN	B-NP	O
a	a	DT	I-NP	O
month	month	NN	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
began	begin	VBD	B-VP	O
experiencing	experience	VBG	I-VP	O
progressive	progressive	JJ	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
which	which	WDT	B-NP	O
seemed	seem	VBD	B-VP	O
related	related	JJ	B-ADJP	O
to	to	TO	B-PP	O
exertion	exertion	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
described	describe	VBD	B-VP	O
the	the	DT	B-NP	O
chest	ch	JJS	I-NP	O
pain	pain	NN	I-NP	O
as	as	IN	B-PP	O
burning	burn	VBG	B-VP	O
and	and	CC	I-VP	O
radiating	radiate	VBG	I-VP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
neck	neck	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
gastroesophageal	gastroesophageal	JJ	B-NP	O
reflux	reflux	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
was	be	VBD	B-VP	O
referred	refer	VBN	I-VP	O
for	for	IN	B-PP	O
EGD	EGD	NN	B-NP	B-protein
,	,	,	O	O
but	but	CC	O	O
this	this	DT	B-NP	O
test	test	NN	I-NP	O
was	be	VBD	B-VP	O
postponed	postpone	VBN	I-VP	O
until	until	IN	B-SBAR	O
a	a	DT	B-NP	O
further	further	JJ	I-NP	O
workup	workup	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
chest	ch	JJS	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
baseline	baseline	NN	B-NP	O
he	he	PRP	B-NP	O
reports	report	VBZ	B-VP	O
exercise-related	exercise-related	JJ	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
everyday	everyday	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
occasional	occasional	JJ	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
at	at	IN	B-PP	O
rest	rest	NN	B-NP	O
relieved	relieve	VBN	B-VP	O
by	by	IN	B-PP	O
about	about	RB	B-NP	O
3-5	3-5	CD	I-NP	O
nitroglycerin	nitroglycerin	NN	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
episodes	episode	NNS	I-NP	O
are	be	VBP	B-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
diaphoresis	diaphoresis	NN	B-NP	O
,	,	,	O	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
but	but	CC	O	O
no	no	DT	B-NP	O
nausea	nausea	NN	I-NP	O
or	or	CC	I-NP	O
vomiting	vomiting	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Significant	Significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
gastritis	gastritis	NN	B-NP	O
,	,	,	O	O
GERD	GERD	NN	B-NP	O
,	,	,	O	O
GI	GI	NN	B-NP	O
bleed	bleed	NN	I-NP	O
in	in	IN	B-PP	O
February	February	NNP	B-NP	O
of	of	IN	B-PP	O
1999	1999	CD	B-NP	O
,	,	,	O	O
nephrolithiasis	nephrolithiasis	NN	B-NP	O
,	,	,	O	O
diabetes	diabetes	NN	B-NP	O
,	,	,	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
,	,	,	O	O
asthma	asthma	NN	B-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
hypercholesterolemia	hypercholesterolemia	NN	B-NP	O
.	.	.	O	O

ADMISSION	ADMISSION	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Cardizem	Cardizem	NN	B-NP	O
,	,	,	O	O
Klonopin	Klonopin	NN	B-NP	O
,	,	,	O	O
aspirin	aspirin	NN	B-NP	O
,	,	,	O	O
Prilosec	Prilosec	NNP	B-NP	O
,	,	,	O	O
Paxil	Paxil	NNP	B-NP	O
,	,	,	O	O
nitroglycerin	nitroglycerin	NN	B-NP	O
,	,	,	O	O
p.r.n.	p.r.n.	NN	B-NP	O
,	,	,	O	O
Azmacort	Azmacort	NN	B-NP	O
,	,	,	O	O
albuterol	albuterol	NN	B-NP	O
,	,	,	O	O
Mevacor	Mevacor	NN	B-NP	O
,	,	,	O	O
iron	iron	NN	B-NP	O
,	,	,	O	O
NPH	NPH	NN	B-NP	B-protein
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
None	None	NN	B-NP	O
known	know	VBN	B-VP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	JJ	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
Afebrile	Afebrile	NN	B-NP	O
,	,	,	O	O
pulse	pulse	NN	B-NP	O
71	71	CD	I-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
107/53	107/53	CD	I-NP	O
,	,	,	O	O
satting	satte	VBG	B-VP	O
97	97	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

Pertinent	Pertinent	JJ	B-NP	O
positive	positive	JJ	I-NP	O
include	include	VBP	B-VP	O
occasional	occasional	JJ	B-NP	O
bilateral	bilateral	JJ	I-NP	O
wheezes	wheeze	NNS	I-NP	O
on	on	IN	B-PP	O
lung	lung	NN	B-NP	O
exam	exam	NN	I-NP	O
.	.	.	O	O

CARDIOVASCULAR	CARDIOVASCULAR	NN	B-NP	O
:	:	:	O	O
Regular	Regular	JJ	B-NP	O
rate	rate	NN	I-NP	O
,	,	,	O	O
normal	normal	JJ	B-NP	O
S1	S1	NN	I-NP	B-protein
and	and	CC	O	O
S2	S2	NN	B-NP	B-protein
,	,	,	O	O
no	no	DT	B-NP	O
murmurs	murmur	NNS	I-NP	O
,	,	,	O	O
rubs	rub	NNS	B-NP	O
,	,	,	O	O
or	or	CC	O	O
gallops	gallop	NNS	B-NP	O
.	.	.	O	O

NECK	NECK	NN	B-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
JVD	JVD	NN	B-NP	B-protein
and	and	CC	O	O
no	no	DT	B-NP	O
carotid	carotid	NN	I-NP	O
bruits	bruit	NNS	I-NP	O
.	.	.	O	O

ABDOMEN	ABDOMEN	NN	B-NP	O
:	:	:	O	O
Benign	Benign	NNP	B-NP	O
.	.	.	O	O

EXTREMITIES	EXTREMITIES	NNS	B-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
cyanosis	cyanosis	NN	I-NP	O
,	,	,	I-NP	O
clubbing	clubbing	NN	I-NP	O
or	or	CC	I-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
dorsalis	dorsalis	NN	B-NP	O
pedis	pedis	NN	I-NP	O
and	and	CC	O	O
posterior	posterior	JJ	B-NP	O
tibialis	tibialis	NN	I-NP	O
pulses	pulse	NNS	I-NP	O
were	be	VBD	B-VP	O
2	2	CD	B-NP	O
+	+	SYM	B-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

RECTAL	RECTAL	NN	B-NP	O
:	:	:	O	O
Significant	Significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
guaiac-positive	guaiac-positive	JJ	B-NP	O
dark	dark	JJ	I-NP	O
brown	brown	JJ	I-NP	O
stool	stool	NN	I-NP	O
.	.	.	O	O

ADMISSION	ADMISSION	NN	B-NP	O
LABORATORY	LABORATORY	NN	I-NP	O
:	:	:	O	O
Significant	Significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
hematocrit	hematocrit	NN	B-NP	O
of	of	IN	B-PP	O
29.4	29.4	CD	B-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
MCV	MCV	NN	I-NP	O
of	of	IN	B-PP	O
78	78	CD	B-NP	O
,	,	,	O	O
cardiac	cardiac	JJ	B-NP	B-protein
enzymes	enzyme	NNS	I-NP	I-protein
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	B-protein
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
showed	show	VBD	B-VP	O
normal	normal	JJ	B-NP	O
sinus	sinus	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
70	70	CD	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
significant	significant	JJ	I-NP	O
ST	ST	NN	I-NP	O
or	or	CC	I-NP	O
T	T	NN	I-NP	O
wave	wave	NN	I-NP	O
abnormalities	abnormality	NNS	I-NP	O
.	.	.	O	O

PROCEDURES	PROCEDURES	NNS	B-NP	O
:	:	:	O	O
Cardiac	Cardiac	JJ	B-NP	O
catheterization	catheterization	NN	I-NP	O
status	status	NN	I-NP	O
post	post	IN	B-PP	O
right	right	JJ	B-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
stent	stent	NN	I-NP	O
was	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
hospital	hospital	NN	I-NP	O
stay	stay	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
complications	complication	NNS	I-NP	O
resulted	result	VBD	B-VP	O
from	from	IN	B-PP	O
this	this	DT	B-NP	O
procedure	procedure	NN	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
BY	BY	NN	I-NP	O
PROBLEM	PROBLEM	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-ADJP	O
.	.	.	O	O

On	On	IN	B-PP	O
February	February	NNP	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
exercise	exercise	NN	I-NP	O
treadmill	treadmill	NN	I-NP	O
test	test	NN	I-NP	O
Bruce	Bruce	NNP	I-NP	O
protocol	protocol	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
exercised	exercise	VBD	B-VP	O
for	for	IN	B-PP	O
2	2	CD	B-NP	O
minutes	minute	NNS	I-NP	O
and	and	CC	O	O
30	30	CD	B-NP	O
seconds	second	NNS	I-NP	O
achieving	achieve	VBG	B-VP	O
a	a	DT	B-NP	O
maximum	maximum	NN	I-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
104	104	CD	B-NP	O
with	with	IN	B-PP	O
maximum	maximum	JJ	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
of	of	IN	B-PP	O
130/90	130/90	CD	B-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
test	test	NN	I-NP	O
was	be	VBD	B-VP	O
terminated	terminate	VBN	I-VP	O
at	at	IN	B-PP	O
low	low	JJ	B-NP	O
exercise	exercise	NN	I-NP	O
level	level	NN	I-NP	O
for	for	IN	B-PP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
an	an	DT	B-NP	O
leg	leg	NN	I-NP	O
fatigue	fatigue	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
EKG	EKG	NN	I-NP	O
changes	change	NNS	I-NP	O
were	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
test	test	NN	I-NP	O
.	.	.	O	O

Since	Since	IN	B-SBAR	O
this	this	DT	B-NP	O
test	test	NN	I-NP	O
was	be	VBD	B-VP	O
nondiagnostic	nondiagnostic	JJ	B-ADJP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
scheduled	schedule	VBN	I-VP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
dobutamine	dobutamine	NN	I-NP	O
MIBI	MIBI	NNP	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
test	test	NN	I-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
significant	significant	JJ	I-NP	O
area	area	NN	I-NP	O
of	of	IN	B-PP	O
ischemia	ischemia	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
inferior	inferior	JJ	I-NP	O
and	and	CC	I-NP	O
apical	apical	JJ	I-NP	O
regions	region	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
heart	heart	NN	I-NP	O
.	.	.	O	O

An	An	DT	B-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
performed	perform	VBN	B-VP	O
also	also	RB	B-ADVP	O
showed	show	VBD	B-VP	O
an	an	DT	B-NP	O
area	area	NN	I-NP	O
of	of	IN	B-PP	O
hypokinesis	hypokinesis	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
inferior	inferior	JJ	I-NP	B-DNA
region	region	NN	I-NP	I-DNA
of	of	IN	B-PP	O
the	the	DT	B-NP	O
heart	heart	NN	I-NP	O
.	.	.	O	O

Cardiac	Cardiac	JJ	B-NP	O
catheterization	catheterization	NN	I-NP	O
performed	perform	VBN	B-VP	O
on	on	IN	B-PP	O
February	February	NNP	B-NP	O
showed	show	VBD	B-VP	O
100	100	CD	B-NP	O
%	%	NN	I-NP	O
occlusion	occlusion	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
LAD	LAD	NN	I-NP	O
and	and	CC	O	O
75	75	CD	B-NP	O
%	%	NN	I-NP	O
occlusion	occlusion	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
with	with	IN	B-PP	O
stent	stent	JJ	B-NP	O
placement	placement	NN	I-NP	O
.	.	.	O	O

Prior	Prior	RB	B-ADVP	O
to	to	TO	B-PP	O
stent	stent	JJ	B-NP	O
placement	placement	NN	I-NP	O
,	,	,	O	O
Mr.	Mr.	NNP	B-NP	O
Niesborella	Niesborella	NNP	I-NP	O
had	have	VBD	B-VP	O
two	two	CD	B-NP	O
episodes	episode	NNS	I-NP	O
of	of	IN	B-PP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
which	which	WDT	B-NP	O
resolved	resolve	VBD	B-VP	O
with	with	IN	B-PP	O
nitroglycerin	nitroglycerin	NN	B-NP	B-protein
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
chest	ch	JJS	I-NP	O
pain	pain	NN	I-NP	O
following	follow	VBG	B-PP	O
stent	stent	JJ	B-NP	O
placement	placement	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
also	also	RB	B-ADVP	O
had	have	VBD	B-VP	O
transient	transient	JJ	B-NP	O
episodes	episode	NNS	I-NP	O
of	of	IN	B-PP	O
atrial	atrial	JJ	B-NP	O
fibrillation/flutter	fibrillation/flutter	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Gastrointestinal	Gastrointestinal	JJ	B-ADJP	O
.	.	.	O	O

Mr.	Mr.	NNP	B-NP	O
Tangerman	Tangerman	NNP	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	B-PP	O
guaiac	guaiac	NN	B-NP	O
positive	positive	JJ	B-ADJP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
also	also	RB	B-ADVP	O
reported	report	VBD	B-VP	O
some	some	DT	B-NP	O
symptoms	symptom	NNS	I-NP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
gastroesophageal	gastroesophageal	JJ	B-NP	O
reflux	reflux	NN	I-NP	O
.	.	.	O	O

While	While	IN	B-SBAR	O
in	in	IN	B-PP	O
inpatient	inpatient	NN	B-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
Prilosec	Prilosec	NNP	I-NP	O
was	be	VBD	B-VP	O
increased	increase	VBN	I-VP	O
at	at	IN	B-PP	O
20	20	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
GI	GI	NN	B-NP	O
while	while	IN	B-SBAR	O
in	in	IN	B-PP	O
inpatient	inpatient	NN	B-NP	O
and	and	CC	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
recommended	recommend	VBN	I-VP	O
that	that	IN	B-SBAR	O
he	he	PRP	B-NP	O
have	have	VBP	B-VP	O
a	a	DT	B-NP	O
repeat	repeat	NN	I-NP	O
EGD	EGD	NN	I-NP	O
and	and	CC	I-NP	O
colonoscopy	colonoscopy	NN	I-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Albuterol	Albuterol	NNP	B-NP	O
inhaler	inhal	JJR	B-NP	O
2	2	CD	I-NP	O
puffs	puff	NNS	I-NP	O
inhaled	inhale	VBD	B-VP	O
q.i.d.	q.i.d.	NN	B-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
wheezing	wheezing	NN	I-NP	O
,	,	,	O	O
enteric	enteric	JJ	B-NP	O
coated	coated	JJ	I-NP	O
aspirin	aspirin	NN	I-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
Klonopin	Klonopin	NNP	B-NP	O
0.5	0.5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
insulin	insulin	NN	B-NP	O
NPH	NPH	NN	I-NP	O
25	25	CD	B-NP	O
units	unit	NNS	I-NP	O
subq	subq	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
,	,	,	O	O
Mevacor	Mevacor	NNP	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
Lopressor	Lopressor	NNP	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
nitroglycerin	nitroglycerin	NN	B-NP	B-protein
p.r.n.	p.r.n.	NN	I-NP	I-protein
chest	chest	NN	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
,	,	,	O	O
Prilosec	Prilosec	NNP	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
Azmacort	Azmacort	NNP	B-NP	O
4	4	CD	I-NP	O
puffs	puff	NNS	I-NP	O
inhaled	inhale	VBD	B-VP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
Paxil	Paxil	NNP	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
clopidogrel	clopidogrel	NN	B-NP	O
75	75	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-NP	O
q.d.	q.d.	FW	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-ADJP	O
.	.	.	O	O

DISPOSITION	DISPOSITION	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	B-PP	O
home	home	NN	B-NP	O
.	.	.	O	O

Dictated	Dictate	VBN	B-VP	O
By	By	IN	B-PP	O
:	:	:	O	O
MAXWELL	MAXWELL	NNP	B-NP	O
DYKHOFF	DYKHOFF	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
KO42	KO42	NNP	I-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
VAUGHN	VAUGHN	NNP	B-NP	O
YANOSKY	YANOSKY	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
AM88	AM88	NNP	I-NP	O
CU188/5193	CU188/5193	NNP	I-NP	O
Batch	Batch	NNP	I-NP	O
:	:	:	O	O
65998	65998	CD	B-NP	O
Index	Index	NNP	I-NP	O
No	No	NNP	I-NP	O
.	.	.	O	O

OEDC639P0R	OEDC639P0R	NN	B-NP	O
D	D	NN	I-NP	O
:	:	:	O	O
1/1	1/1	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
1/1	1/1	CD	B-NP	O

